439 related articles for article (PubMed ID: 19125045)
1. Epinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis.
Nichols KK; Morris S; Gaddie IB; Evans D
Eye Contact Lens; 2009 Jan; 35(1):26-31. PubMed ID: 19125045
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
[TBL] [Abstract][Full Text] [Related]
3. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients.
Hom MM
Eye Contact Lens; 2006 Mar; 32(2):109-11. PubMed ID: 16538135
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
[TBL] [Abstract][Full Text] [Related]
6. An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis.
Ousler GW; Workman DA; Torkildsen GL
Clin Ther; 2007 Apr; 29(4):611-6. PubMed ID: 17617284
[TBL] [Abstract][Full Text] [Related]
7. Role of hypo-osmotic saline drops in ocular comfort during contact lens wear.
Stahl U; Willcox M; Stapleton F
Cont Lens Anterior Eye; 2010 Apr; 33(2):68-75. PubMed ID: 20117960
[TBL] [Abstract][Full Text] [Related]
8. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.
Villareal AL; Farley W; Pflugfelder SC
Eye Contact Lens; 2006 Dec; 32(6):272-6. PubMed ID: 17099387
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study Between an Oil-in-Water Emulsion and Nonlipid Eye Drops Used for Rewetting Contact Lenses.
Guthrie SE; Jones L; Blackie CA; Korb DR
Eye Contact Lens; 2015 Nov; 41(6):373-7. PubMed ID: 26488155
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a new multi-purpose disinfecting solution in symptomatic contact lens wearers.
Stiegemeier MJ; Friederichs GJ; Hughes JL; Larsen S; Movic W; Potter WB
Cont Lens Anterior Eye; 2006 Jul; 29(3):143-51. PubMed ID: 16698309
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
Fujishima H; Ohashi Y; Takamura E
Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
[TBL] [Abstract][Full Text] [Related]
14. Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.
Trattler WB; Luchs J; Majmudar P
Int Ophthalmol Clin; 2006; 46(4):87-99. PubMed ID: 17060795
[No Abstract] [Full Text] [Related]
15. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo performance of epinastine hydrochloride-releasing contact lenses.
Minami T; Ishida W; Kishimoto T; Nakajima I; Hino S; Arai R; Matsunaga T; Fukushima A; Yamagami S
PLoS One; 2019; 14(1):e0210362. PubMed ID: 30699147
[TBL] [Abstract][Full Text] [Related]
17. Effects of topical application of ibudilast for seasonal allergic conjunctivitis in patients wearing soft contact lenses.
Sakuma K; Toshida H; Honda R; Tanaka K; Fukazawa A; Takahashi K; Suto C; Ebihara N; Murakami A
Eye Contact Lens; 2009 Sep; 35(5):251-4. PubMed ID: 19672196
[TBL] [Abstract][Full Text] [Related]
18. Epinastine in the management of ocular allergic disease.
Friedlaender MH
Int Ophthalmol Clin; 2006; 46(4):85-6. PubMed ID: 17060794
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis.
Whitcup SM; Bradford R; Lue J; Schiffman RM; Abelson MB
Clin Ther; 2004 Jan; 26(1):29-34. PubMed ID: 14996515
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
Leonardi A; Zafirakis P
Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
